Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3897066010 | Ubrogepant (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3897067018 | Ubrogepant | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ubrogepant (substance) | Is a | Heterocyclic compound | true | Inferred relationship | Some | ||
| Ubrogepant (substance) | Has disposition (attribute) | Calcitonin gene-related peptide receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| Ubrogepant (substance) | Is a | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ubrogepant only product | Has active ingredient | True | Ubrogepant (substance) | Inferred relationship | Some | 1 |
| Ubrogepant-containing product in oral dose form | Has active ingredient | True | Ubrogepant (substance) | Inferred relationship | Some | 1 |
| Product containing ubrogepant (medicinal product) | Has active ingredient | True | Ubrogepant (substance) | Inferred relationship | Some | 1 |
| Ubrogepant only product in oral dose form | Has active ingredient | True | Ubrogepant (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR